Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697830 | SCV000492229 | likely benign | not provided | 2017-10-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000803894 | SCV000943781 | likely benign | Duchenne muscular dystrophy | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446637 | SCV002677799 | uncertain significance | Cardiovascular phenotype | 2023-06-22 | criteria provided, single submitter | clinical testing | The p.S281T variant (also known as c.842G>C), located in coding exon 9 of the DMD gene, results from a G to C substitution at nucleotide position 842. The serine at codon 281 is replaced by threonine, an amino acid with similar properties. Based on data from gnomAD, the C allele has an overall frequency of 0.0071% (11/154599) total alleles studied, with 2 hemizygote(s) observed. The highest observed frequency was 0.0151% (10/66325) of European (non-Finnish) alleles. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |